search

Coffee Chat in YOUR City | Meeting with Student Ambassador

  • Date: January 17, 2020
  • Location: RIGHT IN YOUR CITY
  • Speakers: Lina-AYENEW, Ryan HYEON, Clément JEAN, Rio RUAN, Heidi JIAN, Daniel LEE, Dee ZHANG, Joshua YUAN, Brandon MENG, Francis WANG, Natalie WANG, Hin LIU, Jay ZHOU

Want to learn about the real life of CKGSB MBA students? Not quite clear about the uniqueness of CKGSB? Faced with some problems when preparing for MBA application? Email us and talk with our current students!

Meet the Counselor

  • Date: January 8, 2020
  • Location: Beijing

CKGSB MBA Program and Embassy of Israel in China are going to co-host the “Meet the Counselor” event on January 8th, 2020 from 19:00-21:00 at CKGSB Beijing Campus. Prestigious speakers including Erez Katz Volovelsky, Counselor, Spokesperson, Director of Communication & Public Diplomacy of Embassy of Israel, and Dr. LI Yang, Associate Professor of Marketing of CKGSB, Academic Director for MBA, will gather here to decode the ecosystem of Israel innovation.

2019 Women in Leadership Forum

  • Date: November 20, 2019
  • Location: Beijing
  • Speakers: TENG Bingsheng, ZHANG Xiaomeng

While issues surrounding gender equality in the workplace have become more prominent than before, women continue to face a myriad of challenges in the workplace and particularly at the senior leadership level.

CKGSB MBA Coffee Chat in Kuala Lumpur

  • Date: November 13, 2019
  • Location: Kuala Lumpur

Date: 2019.11.13 Time: 19:30-21:30 Location: Pullman Kuala Lumpur, 4 Jalan Conlay, 50450, Kuala Lumpur

CKGSB MBA Coffee Chat – Singapore

  • Date: November 11, 2019
  • Location: Singapore

Date: November 11, 2019 Time: 19:30-21:30 Venue: Yotel Singapore, 366 Orchard Road, 238904, Singapore

CKGSB MBA Coffee Chat – Bangkok, Thailand

  • Date: November 9, 2019
  • Location: Bangkok

Date: November 9th, 2019 Time: 13:00-14:30 Location: Hotel Sofitel Bangkok Sukhumvit, 189 Sukhumvit Road Soi 13-15, Klongtoey Nua Wattana, Bangkok,Thailand 10110

China’s Healthcare Reform – Challenges and Opportunities

  • Date: November 4, 2019
  • Location: Beijing

In a recent shake-up, China rolled out the “4+7” bulk-buying policy in an effort to drive down prices of generic drugs and force local players to become more globally competitive by investing in more R&D. What does China's new healthcare policy mean for established multinational and Chinese pharmaceutical companies? CKGSB Professor of Finance Li Haitao explains.

Understand China from the inside

Subscribe to our monthly newsletter today!